TRILEPTAL 60 mg/ml, oral suspension bottle, 250 ml
Brand page: Trileptal (oxcarbazepine) — all forms and strengths in France
Active ingredients: Oxcarbazepine
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 250 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRILEPTAL 60 mg/ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 250 ml avec adaptateur avec seringue(s) pour administration orale polypropylène
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Aug 2003
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66064587CIP73579012CIP133400935790125Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OXCARBAZÉPINEsuspension | 60 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.